Press Release: BERG : BERG To Conduct Phase Two Trial For Treatment Of Deadly Glioblastoma Multiforme [GBM]

FRAMINGHAM, Mass., March 22, 2021 /PRNewswire/ -- BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today announced with leading cancer centers that the Federal Drug Administration [FDA] has...